Company Spotlight

Concise Engineering

4625 East Bay Drive
207
Clearwater, FL 33764
United States
View Profile


Outsourcing Directory


Arthur G. Russell Co. Inc., The





Company Headquarters

750 Clark Avenue
Bristol, CT 06010
United States

Company Description

The Arthur G. Russell Co., Inc. (AGR) is a world leader in custom assembly machinery. AGR has many years of experience in developing automated assembly equipment and processes for the medical device and diagnostics industry. We have been involved in projects from inception to completion utilizing our top of the line automated assembly machines. Many of the products we have worked on have become the market leaders in their segment of the industry. Automated assembly equipment and automated assembly systems from AGR can help you deliver a new product to the marketplace in an accelerated time frame. This can be accomplished in stages beginning with laboratory prototype equipment production lines and progressing through scale up into high-volume production as market demands increase. We also have developed a network of highly specialized resources in fields critical to the development process. We design custom automation systems that will exceed your expectations and grow with you as your medical product demands change. We are a preferred turnkey automation system manufacturer with a team that delivers effective results.

Outsourcing Directory

    Related Content

    • ZipThaw Receives FDA Clearance

      ZipThaw Receives FDA Clearance

      A dry, portable precise plasma thawing medical device.
      PRNewswire 01.06.20

    • Materials
      Avoiding Problems While Collaborating in the Medical Textile Industry

      Avoiding Problems While Collaborating in the Medical Textile Industry

      When to include or exclude an inventor from a patent application.
      Mareesa Frederick and Courtney Bolin, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 12.19.19

    • ControlRad Expands Leadership Team

      ControlRad Expands Leadership Team

      Ramps up commercialization of ControlRad Trace.
      ControlRad Inc. 12.17.19


    • Cardiovascular | Neurological
      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      Imperative Care Closes a Series C Financing of $85 Million for Stroke Treatments

      The funds will support the commercial launch of the company’s portfolio.
      Imperative Care Inc. 12.10.19

    • Diagnostics | Neurological
      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      Represents cost savings and increased quality of care.
      MaxQ AI 12.04.19

    • Mike on Medtech: The Special 510(k) Program

      Mike on Medtech: The Special 510(k) Program

      Mike Drues and Sean Fenske discuss a 510(k) option for modifications to a company's legally marketed medical device.
      Sean Fenske, Editor-in-Chief 11.13.19


    • Cardiovascular | Neurological
      Anaconda Biomed Completes First-in-Human Study of Thrombectomy System

      Anaconda Biomed Completes First-in-Human Study of Thrombectomy System

      Trial Data will support regulatory submission to FDA.
      Business Wire 11.05.19

    • Fiasp Approved for Use with the Omnipod System in the U.S.

      Fiasp Approved for Use with the Omnipod System in the U.S.

      An ultra-fast-acting insulin developed by Novo Nordisk.
      Insulet Corporation 10.29.19

    • Packaging & Sterilization
      Top Surgeons Write Letter to the FDA

      Top Surgeons Write Letter to the FDA

      Stress the importance of Ethylene Oxide for medical device sterilization.
      AdvaMed 10.25.19


    • Cardiovascular
      Corvia Medical

      Corvia Medical's Shunt Device Receives Breakthrough Device Designation

      May reduce symptoms and slow the progression of heart failure.
      PRNewswire 10.09.19

    • Innovating for the Clinical Space: An Interview with Clinical Innovations

      Innovating for the Clinical Space: An Interview with Clinical Innovations' President/CEO Ken Reali

      Ken Reali of Clinical Innovations speaks with Sean Fenske about current issues impacting medical device manufacturing and emerging trends influencing care.
      Sean Fenske, Editor-in-Chief 09.06.19